Literature DB >> 21736704

In silico exploration of anti-inflammatory activity of natural coumarinolignoids.

Abha Meena1, Dharmendra K Yadav, Ankit Srivastava, Feroz Khan, Debabrata Chanda, Sunil K Chattopadhyay.   

Abstract

Natural coumarinolignoids isolated from the seeds of Cleome viscosa consist of a racemic mixture of cleomiscosins A, B and C. To screen out potential lead, anti-inflammatory activity of the isolated compounds was evaluated through molecular docking and QSAR studies by using reported in vivo activity of Swiss albino mice. Based on docking binding affinity, a possible mechanism of action has been hypothesized which constitute toll-like receptors (TLR-4), cluster of differentiation molecules (CDs), iNOS, COX-2 and STAT-6 proteins. It was very interesting to find that the 3D topology of the active site of COX-2 from the docking was in good agreement with QSAR model and in silico ADME/T parameters. A forward feed multiple linear regression model was developed with r(2) = 0.92 and rCV(2) = 0.87. This study showed that chemical descriptors, for example dipole vector-X, dipole vector-Y, steric energy, LUMO energy, size of smallest ring, size of largest ring and carboxyl group count, correlate reasonably well with experimental in vivo activity (logLD(50) ). QSAR study indicates that dipole vector-Y and carboxyl group count have negative correlation with activity. Cleomiscosins also showed compliance with 95% of in silico ADME/T properties of available drugs, e.g. serum protein binding, blood-brain barrier, CNS activity, HERG K+ channel activity, apparent Caco-2 permeability, apparent MDCK permeability, skin permeability and human oral absorption in GI. Besides, toxicity screening study suggests that cleomiscosin molecules possess no toxicity risk parameters. This study offer useful references for understanding and molecular design of inhibitors with improved anti-inflammatory activity.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21736704     DOI: 10.1111/j.1747-0285.2011.01173.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  7 in total

1.  Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity.

Authors:  Dharmendra Kumar Yadav; Feroz Khan; Arvind Singh Negi
Journal:  J Mol Model       Date:  2011-10-27       Impact factor: 1.810

2.  Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Authors:  Komal Kalani; Dharmendra Kumar Yadav; Feroz Khan; Santosh K Srivastava; Nitasha Suri
Journal:  J Mol Model       Date:  2012-01-21       Impact factor: 1.810

Review 3.  Computer-Aided Drug Design in Epigenetics.

Authors:  Wenchao Lu; Rukang Zhang; Hao Jiang; Huimin Zhang; Cheng Luo
Journal:  Front Chem       Date:  2018-03-12       Impact factor: 5.221

4.  Synthesis of Michael Adducts as Key Building Blocks for Potential Analgesic Drugs: In vitro, in vivo and in silico Explorations.

Authors:  Sajjad Ahmad; Mater H Mahnashi; Bandar A Alyami; Yahya S Alqahtani; Farhat Ullah; Muhammad Ayaz; Muhammad Tariq; Abdul Sadiq; Umer Rashid
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

5.  Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach.

Authors:  Shafi Mahmud; Shamima Afrose; Suvro Biswas; Abir Nagata; Gobindo Kumar Paul; Mohasana Akter Mita; Md Robiul Hasan; Mst Sharmin Sultana Shimu; Shahriar Zaman; Md Salah Uddin; Md Sayeedul Islam; Md Abu Saleh
Journal:  PLoS One       Date:  2022-08-23       Impact factor: 3.752

6.  QSAR and docking studies on capsazepine derivatives for immunomodulatory and anti-inflammatory activity.

Authors:  Aparna Shukla; Pooja Sharma; Om Prakash; Monika Singh; Komal Kalani; Feroz Khan; Dnyaneshwar Umrao Bawankule; Suaib Luqman; Santosh Kumar Srivastava
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

7.  Novel Homo-Bivalent and Polyvalent Compounds Based on Ligustrazine and Heterocyclic Ring as Anticancer Agents.

Authors:  Jiawen Wang; Ge Hong; Guoliang Li; Wenzhi Wang; Tianjun Liu
Journal:  Molecules       Date:  2019-12-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.